Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Masimo Corp (MASI)
NASDAQ:MASI
MASI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$101.61 - $184.51
Previous CloseN/A
Volume102.94K
Average Volume (3M)472.88K
Market Cap
$9.66B
Enterprise Value$7.93B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)123.2
Beta0.87
Next Earnings
Feb 25, 2025EPS Estimate
1.43Last Dividend Ex-Date
Nov 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)1.46
Shares Outstanding53,540,565
10 Day Avg. Volume387,699
30 Day Avg. Volume472,879
Standard Deviation0.12
R-Squared0.20
Alpha-0.00440
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.79
Price to Cash Flow (P/CF)32.40
P/FCF Ratio39.30
Enterprise Value/Market Cap0.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.90
Enterprise Value/Ebitda36.54
Forecast
1Y Price Target
$188.00Price Target Upside4.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Masimo News
PremiumCompany Announcements
Masimo Sets Date for 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Masimo Announces Executive Leadership ChangePremiumCompany Announcements
Masimo Board Member Robert Chapek Announces Resignation
PremiumCompany Announcements
Masimo Appoints New CEO Amid Leadership Transition
PremiumCompany Announcements
Masimo Announces 2024 Financial Results and 2025 Guidance---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFull-year 2024 EPS will surpass the high-end of previous guidance, indicating strong financial performance.
Leadership ChangesInvestors are expected to react favorably to the announcement of Katie Szyman as the new CEO.
Strategic InitiativesA potential separation of its Consumer business is seen as a positive catalyst for MASI, allowing management to focus on its core Healthcare business and pay down debt.
Bears Say
Litigation RiskKey downside risks include litigation risk from AAPL, potential delays or failures in launching new products, and increasing competition in end markets.
Market CompetitionIncreasing competition in end markets poses a risk to MASI's market position and profitability.
Revenue DeclineFor the full year 2024, MASI anticipates a decline in Non-Healthcare revenue by about 10%.
---
Ownership Overview
18.21% Insiders
30.80% Mutual Funds
0.47% Other Institutional Investors
30.63% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MASI FAQ
What was Masimo Corp’s price range in the past 12 months?
Masimo Corp lowest stock price was $101.61 and its highest was $184.51 in the past 12 months.
What is Masimo Corp’s market cap?
Masimo Corp’s market cap is $9.66B.
When is Masimo Corp’s upcoming earnings report date?
Masimo Corp’s upcoming earnings report date is Feb 25, 2025 which is in 4 days.
How were Masimo Corp’s earnings last quarter?
Masimo Corp released its earnings results on Nov 05, 2024. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.837 by $0.143.
Is Masimo Corp overvalued?
According to Wall Street analysts Masimo Corp’s price is currently Undervalued.
Does Masimo Corp pay dividends?
Masimo Corp pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp dividends here
What is Masimo Corp’s EPS estimate?
Masimo Corp’s EPS estimate is 1.43.
How many shares outstanding does Masimo Corp have?
Masimo Corp has 53,540,565 shares outstanding.
What happened to Masimo Corp’s price movement after its last earnings report?
Masimo Corp reported an EPS of $0.98 in its last earnings report, beating expectations of $0.837. Following the earnings report the stock price went up 10.603%.
Which hedge fund is a major shareholder of Masimo Corp?
Currently, no hedge funds are holding shares in MASI
---
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$188.00 (4.78% Upside)
$188.00 (4.78% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 83%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 3.3%
Last 30 Days ▲ 3.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.21%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
3.07%
Trailing 12-Months
Company Description
Masimo Corp
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
---
MASI Company Deck
---
MASI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance in the healthcare segment with significant revenue growth and improved margins. However, challenges persist in the non-healthcare consumer market, which saw a decline in revenue. The company is optimistic about future margin improvements and strategic initiatives, particularly in healthcare.Read More>---
MASI Stock 12 Month Forecast
Average Price Target
$188.00
▲(4.78% Upside)
Technical Analysis
Best Analysts Covering MASI
1 Year
1 Year Success Rate
21/28 ratings generated profit
1 Year Average Return
+17.53%
reiterated a buy rating last month
Copying Rick Wise's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +17.53% per trade.
---